Common Cause for Complications After Kidney Transplantation Identified
The authors of the research group Transplantation & Clinical Virology with Hans H. Hirsch, Min Lu, Julia Manzetti and Ksenia Yakhontova (from left). © University of Basel
Polyomavirus infections are common, however, they usually do not cause symptoms in healthy adults. However, the virus becomes much more problematic for patients who have to take immunosuppressive drugs after kidney transplantation.
In ten to twenty percent of all cases, the BK virus starts to spread within the transplant and causes an inflammation. This can, in the worst case, destroy the new organ entirely and put the patient back on the transplant waiting list.
When it comes to organ transplantation, doctors mainly fight the human immune system, which tries to reject the donor organ. Immunosuppressive drugs, such as the commonly used Tacrolimus, are prescribed to suppress this process.
The substance inhibits signaling between the body's immune cells. However, this treatment also weakens the immune system in such a way that it is no longer able to protect the organism sufficiently from viruses such as said BK virus – a predicament.
Drugs affect virus differently
The Transplantation & Clinical Virology research group from the Department of Biomedicine at the University of Basel led by Professor Hans H. Hirsch was now able to show, that the BK virus reacts completely different to various immunosuppressive drugs: While the commonly used drug Tacrolimus activates the replication of the virus inside kidney cells, the substance Sirolimus, a mTOR inhibitor, inhibits virus replication.
The results explain why in the past ten years an increasing number of cases of BK polyomavirus complications have occurred after the widespread introduction of Tacrolimus in transplantation clinics. The findings also provide important rationales for clinical trials in order to test the use of mTOR inhibitors like Sirolimus in patients in acute danger of loosing their kidney transplant without simultaneously having to increase the risk of organ rejection.
Original source
H. H. Hirsch, K. Yakhontova, M. Li and J. Manzetti
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12
American Journal of Transplantation 2015; XX: 1–12 | doi: 10.1111/ajt.13541
Further Information
Hans H. Hirsch, University of Basel Basel, Department of Biomedicine, phone: +41 (0)61 267 32 25, email: hans.hirsch@unibas.ch
Media Contact
More Information:
http://www.unibas.chAll latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Iron-Nickel-Zirconium Alloy Trigger a New Superconductor Zirconide
Student project uncovers superconductivity in polycrystalline iron nickel zirconide Zirconide: A New Transition Metal Tokyo, Japan – Researchers from Tokyo Metropolitan University have discovered a new superconducting material. They combined…
Heart of the Matter: Effective Anti-Obesity Strategies to Protect Cardiovascular Health
People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalised from a heart attack or heart failure, regardless of their body…
CO2 and Global Warming: How Soils and Plants Challenge Future Droughts
What will the future of our soils – and thus also the availability of water – look like under the influence of imminent climatic changes? An international study led by…